Accessibility Menu
FusionPharm logo

FusionPharm(OTC) FSPM

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)-100%
5 Year-100%
1 Year-99%
1 Month-99%
$0.00
+0.00%
+0.00Today
FusionPharm last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-04
FusionPharm stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99%USD 0.002026-07-27
1 month-99%USD 0.002026-06-25
3 month-99%USD 0.002026-05-06
Year to date-99%USD 0.002025-12-30
1 year-99%USD 0.002025-08-04
3 year-99.5%USD 0.002023-07-28
5 year-99.5%USD 0.002021-08-05
Since inception-100%USD 1,874,906.251993-04-27

FusionPharm Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-31.66 (Low)

Price

$0.00

Volume

480

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

FSPM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About FusionPharm

FusionPharm, Inc. specializes in the development, manufacturing, and sale of advanced indoor cultivation systems. The company markets its products under the PharmPod brand, catering to a diverse clientele across the United States.

Products and Services
  • Advanced indoor cultivation systems for various plant types
  • PharmPod brand units designed for commercial and individual use
  • Support for academic institutions and research facilities
Growth Outlook
  • Established market presence since 1998 with a strong brand identity
  • Increasing demand for indoor cultivation solutions in diverse sectors
  • Potential for expansion into new markets and customer segments
Financial Highlights
  • Market capitalization of $1,259, indicating growth potential
  • Stock price range between $0.0001 and $0.0002 over the year
  • Low beta of -0.448 suggests less volatility compared to the market
FusionPharm, Inc. has positioned itself as a key player in the indoor cultivation market, leveraging its innovative PharmPod systems to meet the needs of various customers. The company's long-standing history and commitment to quality have contributed to its reputation in the industry. With a focus on expanding its market reach, FusionPharm is well-placed to capitalize on the growing interest in indoor agriculture. The financial highlights indicate a stable market presence, with a low stock price range that may attract investors looking for opportunities in the healthcare sector.
AI Generated • Aug 9, 2026

Industry

Food Products

Sector

Consumer Staples

Headquarters

Commerce City, CO 80022, US

FSPM Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.59M

Volume

480

Avg. Volume

418.54

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

FusionPharm Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIMIBIMI International Medical Inc.
$0.00+0.00%
BNKLBionik Laboratories Corp.
$0.00+0.00%
ISHIIslet Holdings, Inc.
$0.00+0.00%
BGMDBG Medicine, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.81+0.06%
SPCXSpace Exploration Technologies
$134.00-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.88-0.03%
IBITiShares Bitcoin Trust
$41.20+0.06%

Questions About FSPM

What is the current price of FusionPharm?

FusionPharm is trading at $0.00 per share.

What is the 52-week range for FusionPharm?

Over the past 52 weeks, FusionPharm has traded between $0.00 and $0.00.

How much debt does FusionPharm have?

FusionPharm total debt is unavailable.

How much cash does FusionPharm have on hand?

FusionPharm does not have cash on hand data available.

What is FusionPharm’s dividend yield?

FusionPharm does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services